Search Results 1301-1310 of 16127 for alt

1. STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS - Mayo Clinic

   AST and ALT ≤ 3 × upper limit of normal (ULN). Total bilirubin ≤ 2 × ULN (except in the setting of isolated Gilbert syndrome). Estimated Glomerular ...

2. A Study to Determine the Effectiveness and Safety of Benralizumab for Patients with Severe Nasal Polyposis - Mayo Clinic

   Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) level ≥ 3 times the upper limit of normal (ULN) confirmed during screening period.

3. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma - Mayo Clinic

   Alanine aminotransferase (ALT) > 3 x ULN; Aspartate aminotransferase (AST) > 3 x ULN; Absolute neutrophil count (ANC) < 1.0 x 10^9/L; Absolute lymphocyte count ...

4. Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer - Mayo Clinic

   Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 1.5 X ULN; < 3 X ULN if known hepatic metastases; Hemoglobin >= 9 g/dL continuation of ...

5. Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors - Mayo Clinic

   Alanine transaminase (ALT) ≤ 110 U/L; Serum albumin ≥ 2 g/dL; Blood glucose normal; Not pregnant or nursing; Negative pregnancy test; Fertile patients must ...

6. Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS) - Mayo Clinic

   ALT or AST > 8 x Upper Limit of Normal (ULN). 8. Documented history of cirrhosis. 9. DNR order, as in electing not to receive chest compressions, cardiac ...

7. A Study Comparing The Effectiveness And Safety Of Combining Three Versus Two Oral Treatments For The Initial Therapy Of Patients Who Have Newly Diagnosed Hypertension Of The Pulmonary Artery - Mayo Clinic

   Serum AST and/or alanine aminotransferase (ALT) > 3 × ULN (assessed at screening). Severe renal impairment (estimated creatinine clearance ≤ 30 mL/min/1.73 ...

8. Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients - Mayo Clinic

   Aspartate aminotransferase (AST) and/or Alanine Aminotransferase (ALT) superior to 3 x ULN. Hypersensitivity to IMiDs (thalidomide or lenalidomide) defined ...

9. CC-4047 in Treating Patients With Myelofibrosis - Mayo Clinic

   Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) ≤ 3 times upper limit of normal (ULN) (≤ 5 times ULN if attributed to hepatic ...

10. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

    Alanine aminotransferase level (ALT) ≤2.5 times the ULN;; Aspartate aminotransferase (AST) ≤2.5 times the ULN;; Total bilirubin level ≤1.5 × ULN except for ...